A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity

Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain l...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 64; no. 3; pp. 1362 - 1391
Main Authors Zhang, Xin-Hui, Qin-Ma, Wu, Hui-Pan, Khamis, Mussa Yussuf, Li, Yi-Han, Ma, Li-Ying, Liu, Hong-Min
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 11.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications.
AbstractList Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications.Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications.
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications.
Author Ma, Li-Ying
Khamis, Mussa Yussuf
Liu, Hong-Min
Qin-Ma
Wu, Hui-Pan
Zhang, Xin-Hui
Li, Yi-Han
AuthorAffiliation China Meheco Topfond Pharmaceutical Co., Ltd
Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
AuthorAffiliation_xml – name: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– name: China Meheco Topfond Pharmaceutical Co., Ltd
Author_xml – sequence: 1
  givenname: Xin-Hui
  surname: Zhang
  fullname: Zhang, Xin-Hui
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– sequence: 2
  surname: Qin-Ma
  fullname: Qin-Ma
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– sequence: 3
  givenname: Hui-Pan
  surname: Wu
  fullname: Wu, Hui-Pan
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– sequence: 4
  givenname: Mussa Yussuf
  surname: Khamis
  fullname: Khamis, Mussa Yussuf
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– sequence: 5
  givenname: Yi-Han
  surname: Li
  fullname: Li, Yi-Han
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
– sequence: 6
  givenname: Li-Ying
  orcidid: 0000-0002-7186-8259
  surname: Ma
  fullname: Ma, Li-Ying
  email: maliying@zzu.edu.cn
  organization: China Meheco Topfond Pharmaceutical Co., Ltd
– sequence: 7
  givenname: Hong-Min
  orcidid: 0000-0001-6771-9421
  surname: Liu
  fullname: Liu, Hong-Min
  email: liuhm@zzu.edu.cn
  organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33523672$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtPGzEUha2KqgTaf1BVXnYz6fVjHmGHoBQkpCJo16M7zp3GaDJOfT2g_PuaJnTRBaws65zPlr5zJA7GMJIQHxXMFWj1BR3P79e0dCtaz8GBqhv9RsxUqaGwDdgDMQPQutCVNofiiPkeAIzS5p04NKbUpqr1TMRTeUsPnh5l6OVNDL8iMUs_ykvPKX8ozwkdpe2ATLKSV-PKdz6FyBljwuhWJ_IuxcmlKeIg7zbkfO-dT1uJ41JeTKNLPow5OvcPFDkH78XbHgemD_vzWPy8-Prj7LK4_v7t6uz0ukCrbCoMNTW5rrGVrkprtcOlg66HDmunFTaq1gvsqgU0ZdmVttEIC9NXHWG-LDWYY_F59-4mht8TcWrXnh0NA44UJm61zaQyqlnk6qd9deqy0nYT_Rrjtn32lAt2V3AxMEfq_1UUtE9ztHmO9nmOdj9Hxk7-w7IZfBKSIvrhNRh28N80TDFb5JeRPzxJpa0
CitedBy_id crossref_primary_10_1021_acs_jmedchem_2c00853
crossref_primary_10_1016_j_bmcl_2024_129670
crossref_primary_10_1021_acs_jmedchem_1c02067
crossref_primary_10_3390_ijms231710014
crossref_primary_10_1016_j_molstruc_2023_134952
crossref_primary_10_3390_ijms23179592
crossref_primary_10_3389_fphar_2022_1064485
crossref_primary_10_1021_acs_jmedchem_1c00966
crossref_primary_10_1080_0886022X_2024_2415517
crossref_primary_10_3390_ph18030351
crossref_primary_10_1016_j_ejmech_2021_113392
crossref_primary_10_1055_s_0042_1749373
crossref_primary_10_1021_acsmedchemlett_2c00081
crossref_primary_10_1021_acs_jmedchem_1c01897
crossref_primary_10_1080_13102818_2024_2362842
crossref_primary_10_26508_lsa_202201645
crossref_primary_10_1021_acs_jmedchem_4c00836
crossref_primary_10_1016_j_compbiolchem_2024_108051
crossref_primary_10_1080_07391102_2023_2272751
crossref_primary_10_3390_ijms23041961
crossref_primary_10_1021_acs_jmedchem_4c01168
crossref_primary_10_2174_0929867328666210902145102
crossref_primary_10_1016_j_ejmech_2024_116676
crossref_primary_10_3390_cells11233825
crossref_primary_10_1016_j_ejmech_2021_113825
crossref_primary_10_3390_molecules29194653
crossref_primary_10_1021_acsptsci_2c00004
crossref_primary_10_1016_j_ejmech_2021_113821
crossref_primary_10_1111_cbdd_14055
crossref_primary_10_1016_j_yexcr_2024_114126
crossref_primary_10_1021_acs_jmedchem_3c00977
crossref_primary_10_3390_ph18030341
crossref_primary_10_3390_molecules27103335
crossref_primary_10_4155_fmc_2021_0040
crossref_primary_10_1080_07391102_2022_2142668
crossref_primary_10_1016_j_jbc_2022_102800
crossref_primary_10_3389_fimmu_2023_1168848
crossref_primary_10_1248_bpb_b23_00603
crossref_primary_10_1016_j_bioorg_2023_106601
crossref_primary_10_1021_acs_jmedchem_3c01385
crossref_primary_10_1016_j_bioorg_2021_105278
crossref_primary_10_1021_acs_jmedchem_3c01345
crossref_primary_10_1002_jhet_4538
crossref_primary_10_1016_j_ejmech_2023_115673
crossref_primary_10_1002_cai2_114
crossref_primary_10_1016_j_ejmech_2023_115752
crossref_primary_10_1161_JAHA_121_024205
crossref_primary_10_1016_j_jscs_2022_101450
crossref_primary_10_1080_13543776_2025_2468792
crossref_primary_10_1021_acs_jmedchem_3c01269
crossref_primary_10_1002_ardp_202300208
crossref_primary_10_1021_acs_jcim_4c01052
crossref_primary_10_3390_pharmaceutics13111893
crossref_primary_10_1007_s00044_022_02987_8
crossref_primary_10_1371_journal_pone_0291779
crossref_primary_10_1016_j_bmcl_2021_128286
crossref_primary_10_1111_exd_14502
crossref_primary_10_1016_j_biopha_2023_114438
crossref_primary_10_1002_cmdc_202400194
crossref_primary_10_1016_j_ejmech_2024_116571
crossref_primary_10_1002_cbic_202100255
crossref_primary_10_1080_14756366_2023_2201408
crossref_primary_10_3390_ph17111536
crossref_primary_10_1016_j_ejmech_2021_113526
crossref_primary_10_1016_j_ejmech_2023_116057
crossref_primary_10_1016_j_ejmech_2023_115367
crossref_primary_10_1016_j_ejmech_2023_115327
crossref_primary_10_1016_j_jddst_2024_106238
crossref_primary_10_2139_ssrn_4195671
crossref_primary_10_1002_asia_202200575
crossref_primary_10_1016_j_ejmech_2022_115004
crossref_primary_10_1128_jvi_01814_23
crossref_primary_10_1016_j_ejphar_2022_175349
crossref_primary_10_1016_j_apsb_2022_09_022
crossref_primary_10_1021_acs_jmedchem_4c00541
crossref_primary_10_1080_14728222_2024_2404571
crossref_primary_10_1111_febs_16703
crossref_primary_10_1016_j_bioorg_2022_105874
crossref_primary_10_1021_acschembio_3c00212
crossref_primary_10_1016_j_compbiomed_2023_107036
crossref_primary_10_1021_acsmedchemlett_1c00425
crossref_primary_10_1016_j_bioorg_2024_107818
crossref_primary_10_1021_acs_jmedchem_2c01418
crossref_primary_10_1021_acs_jmedchem_3c01008
crossref_primary_10_1038_s41598_022_25390_0
crossref_primary_10_1016_j_ejmech_2021_113874
crossref_primary_10_1142_S2737416524500121
Cites_doi 10.3892/or.2016.4811
10.1093/hmg/ddt402
10.1021/jm0506773
10.1016/j.bmc.2018.02.042
10.2174/1568026617666170707124126
10.1080/13880209.2018.1563620
10.1016/j.yjmcc.2018.10.007
10.1016/j.ejmech.2014.03.018
10.1021/acs.jmedchem.9b00946
10.1038/417455a
10.1021/acsmedchemlett.0c00395
10.1016/j.ejmech.2019.112016
10.1016/j.expneurol.2020.113281
10.1016/j.bmcl.2010.12.079
10.1158/2159-8290.CD-16-1020
10.1074/jbc.R112.372300
10.2217/epi.14.69
10.1016/j.bmcl.2006.04.091
10.1021/acs.jmedchem.8b00393
10.3892/ijo.2018.4405
10.3390/ijms20246213
10.1016/j.ejmech.2018.03.006
10.1016/j.bbamcr.2019.03.003
10.1073/pnas.0803749105
10.1038/nchembio.2134
10.1182/blood-2011-10-387365
10.1111/jnc.14849
10.1038/nchembio.1223
10.1016/j.brainresbull.2020.06.010
10.1016/j.phrs.2019.104281
10.1016/j.bmc.2018.10.022
10.1016/j.ejmech.2018.09.024
10.1021/acs.jmedchem.9b00924
10.1016/j.bmc.2017.06.001
10.1111/bjh.12384
10.1021/acsmedchemlett.0c00046
10.1002/cmdc.201500456
10.2174/1568026619666181129141822
10.1016/j.ejmech.2018.03.005
10.1016/j.ccr.2007.08.001
10.1016/j.gore.2019.07.010
10.1016/j.ajpath.2017.12.016
10.1038/nature07348
10.1016/j.phrs.2020.105274
10.1002/ejic.200400221
10.1371/journal.pone.0205018
10.1016/j.yjmcc.2019.04.003
10.1002/med.20056
10.1021/acs.jmedchem.5b01493
10.1016/j.ejmech.2020.112998
10.1016/j.ejmech.2020.112887
10.1021/acs.biochem.9b00934
10.1021/acs.jmedchem.9b00940
10.1021/acs.jmedchem.0c00628
10.1042/BSR20181916
10.1038/nchembio.2140
10.1021/jm990366q
10.1007/s10753-018-0853-0
10.1016/j.bmc.2019.06.036
10.1155/2011/875824
10.1016/j.biopha.2019.109357
10.1021/acs.jmedchem.7b01404
10.1016/j.bmcl.2018.06.037
10.1002/cmdc.201500486
10.1016/j.neuint.2016.08.004
10.1021/acs.jmedchem.0c00567
10.1021/acs.jmedchem.6b00157
10.1007/s13238-018-0602-z
10.1016/j.ejmech.2018.07.069
10.1016/j.bmc.2019.115250
10.1021/acschemneuro.8b00600
10.1038/s41419-018-0788-2
10.4149/gpb_2019058
10.1074/jbc.M111.273730
10.1002/mc.22852
10.1038/sj.onc.1203925
10.1021/acsmedchemlett.8b00487
10.1158/1078-0432.CCR-14-2820
10.1016/j.molcel.2005.04.021
10.1016/j.ejmech.2020.112086
10.1038/s41419-018-0688-5
10.1007/s002800100300
10.1021/acsmedchemlett.9b00084
10.1021/acs.jmedchem.0c00830
10.1021/acs.orglett.8b01118
10.1016/j.ejmech.2016.05.047
10.3390/antiox9070599
10.1021/acsomega.0c00559
10.1038/s41419-020-2586-x
10.1080/07391102.2018.1557560
10.1016/j.pharmthera.2017.02.027
10.1016/j.ejmech.2018.04.046
10.1080/13543776.2018.1526280
10.1016/j.bmcl.2020.127023
10.1073/pnas.1515882112
10.1021/jm020449y
10.1016/j.bmcl.2018.12.052
10.1016/j.ejmech.2020.112193
10.1002/cmdc.201700550
10.3892/ijo.2019.4739
10.1021/acs.jmedchem.9b01540
10.1007/s10495-020-01607-3
10.1021/acs.jmedchem.5b00099
10.1146/annurev.biochem.70.1.369
10.1021/acs.jmedchem.8b01936
10.1016/j.ejmech.2020.112679
10.1056/NEJMoa1513257
10.1016/j.ejmech.2016.03.046
10.3390/cancers11091327
10.1016/j.leukres.2020.106398
10.1080/13543776.2018.1508451
10.1016/j.molcel.2007.05.033
10.1016/j.biopha.2018.11.017
10.1021/acsmedchemlett.9b00560
10.1073/pnas.1718823114
10.1016/j.bmcl.2012.10.007
10.1073/pnas.1313893110
10.1182/blood-2006-06-025999
10.1016/j.bmc.2018.06.023
10.1038/leu.2017.322
10.1002/jcp.29776
10.1021/acs.jmedchem.8b01090
10.1016/j.taap.2019.03.017
10.1158/1535-7163.MCT-17-0603
10.1021/acschemneuro.9b00303
10.1021/acs.jmedchem.0c00193
10.3389/fphar.2019.00653
10.3390/ijms21134589
10.1038/nrd.2016.211
10.3390/ijms18050954
10.1038/nature05913
10.1007/s13311-016-0501-z
10.1073/pnas.0404603101
10.1158/0008-5472.CAN-18-0161
10.1039/C8OB00966J
10.1038/43710
10.1016/j.ejmech.2020.112868
10.1021/jm301098e
10.1021/acsmedchemlett.7b00012
10.1038/450357a
10.1182/blood-2009-04-214957
10.18632/oncotarget.19019
10.1042/CS20171417
10.1016/j.bmc.2018.05.013
10.1016/j.brainres.2020.146692
10.2147/DDDT.S124977
10.1016/j.semcancer.2020.02.006
10.1080/07391102.2016.1231084
10.1021/acs.jmedchem.8b01487
10.2174/0929867325666180327093502
10.1038/nrc1716
10.1371/journal.pone.0173507
10.1016/j.ejmech.2019.111950
10.1016/j.it.2011.04.001
10.1126/science.1172782
10.1016/j.ejmech.2017.10.040
10.1038/s41598-019-42237-3
10.1016/j.molonc.2015.04.002
10.1186/gb-2004-5-12-253
10.1186/s13075-020-02258-0
10.1080/13543776.2019.1708901
10.18632/oncotarget.13738
10.1021/jm200326p
10.1186/s13045-018-0654-9
10.1093/carcin/bgx121
10.1016/j.ijbiomac.2020.06.115
10.1021/jm8002894
10.5582/irdr.2016.01024
10.1186/s40425-019-0517-0
10.1007/s11596-019-2024-4
10.1016/j.cell.2007.02.005
10.1016/j.bcp.2019.03.023
10.1016/j.cell.2007.02.006
10.1021/acs.jmedchem.9b01888
10.1021/acsmedchemlett.7b00223
10.1038/s41375-020-0840-y
10.3390/nano10010161
10.1126/science.1179689
10.1002/jcb.26841
10.1021/acs.jmedchem.8b01590
10.1016/S1470-2045(15)00584-7
10.1021/ja102758v
10.1016/j.bmcl.2018.05.057
10.2174/092986712802884286
10.1021/acs.jmedchem.7b01593
10.1073/pnas.1608067113
10.1038/s41388-020-1172-0
10.1016/j.ejphar.2018.03.026
10.3390/cancers12030756
10.1073/pnas.96.9.4868
10.1152/ajprenal.00186.2017
10.1007/s11064-019-02882-6
10.3389/fnagi.2020.00078
10.1016/j.ejmech.2020.112831
ContentType Journal Article
Copyright 2021 American Chemical Society
Copyright_xml – notice: 2021 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/acs.jmedchem.0c01782
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 1391
ExternalDocumentID 33523672
10_1021_acs_jmedchem_0c01782
a838918514
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID -
.K2
55A
5GY
5RE
5VS
7~N
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ABUCX
ACGFS
ACJ
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
DU5
EBS
ED
ED~
F5P
GNL
IH2
IH9
IHE
JG
JG~
K2
L7B
LG6
P2P
ROL
TN5
UI2
VF5
VG9
W1F
WH7
X
XFK
YZZ
ZY4
---
-~X
4.4
6P2
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ACGFO
ADHLV
AGXLV
AHGAQ
CITATION
CUPRZ
GGK
XSW
YQT
ABTAH
CGR
CUY
CVF
ECM
EIF
NPM
YIN
7X8
ID FETCH-LOGICAL-a414t-3e87ecb846265442cadc0bf0ba7c21a81729ab690855b5482a093f6bea548d203
IEDL.DBID ACS
ISSN 0022-2623
1520-4804
IngestDate Fri Jul 11 13:23:55 EDT 2025
Wed Feb 19 02:29:16 EST 2025
Thu Apr 24 23:11:09 EDT 2025
Tue Jul 01 01:09:53 EDT 2025
Sat Feb 13 03:12:48 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License https://doi.org/10.15223/policy-029
https://doi.org/10.15223/policy-037
https://doi.org/10.15223/policy-045
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a414t-3e87ecb846265442cadc0bf0ba7c21a81729ab690855b5482a093f6bea548d203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6771-9421
0000-0002-7186-8259
PMID 33523672
PQID 2485513189
PQPubID 23479
PageCount 30
ParticipantIDs proquest_miscellaneous_2485513189
pubmed_primary_33523672
crossref_primary_10_1021_acs_jmedchem_0c01782
crossref_citationtrail_10_1021_acs_jmedchem_0c01782
acs_journals_10_1021_acs_jmedchem_0c01782
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-11
PublicationDateYYYYMMDD 2021-02-11
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-11
  day: 11
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of medicinal chemistry
PublicationTitleAlternate J. Med. Chem
PublicationYear 2021
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref99/cit99
ref3/cit3
ref81/cit81
ref16/cit16
ref185/cit185
ref23/cit23
ref115/cit115
ref187/cit187
ref181/cit181
ref111/cit111
ref113/cit113
ref183/cit183
ref117/cit117
ref48/cit48
ref74/cit74
ref189/cit189
ref119/cit119
ref10/cit10
ref35/cit35
ref93/cit93
ref42/cit42
ref120/cit120
ref178/cit178
ref122/cit122
ref61/cit61
ref176/cit176
ref67/cit67
ref128/cit128
ref124/cit124
ref126/cit126
ref54/cit54
ref137/cit137
ref11/cit11
ref102/cit102
ref29/cit29
ref174/cit174
ref86/cit86
ref170/cit170
ref5/cit5
ref43/cit43
ref80/cit80
ref133/cit133
ref28/cit28
ref148/cit148
ref55/cit55
ref144/cit144
ref167/cit167
ref163/cit163
ref66/cit66
ref22/cit22
ref87/cit87
ref106/cit106
ref190/cit190
ref140/cit140
ref194/cit194
ref98/cit98
ref153/cit153
ref150/cit150
ref63/cit63
ref56/cit56
ref155/cit155
ref156/cit156
ref158/cit158
ref8/cit8
ref59/cit59
ref85/cit85
ref34/cit34
ref37/cit37
ref60/cit60
ref17/cit17
ref82/cit82
ref147/cit147
ref145/cit145
ref21/cit21
ref166/cit166
ref164/cit164
ref78/cit78
ref36/cit36
ref83/cit83
ref79/cit79
ref139/cit139
ref172/cit172
ref14/cit14
ref57/cit57
ref169/cit169
ref134/cit134
ref40/cit40
ref131/cit131
ref161/cit161
ref142/cit142
ref15/cit15
ref180/cit180
ref62/cit62
ref41/cit41
ref58/cit58
ref104/cit104
ref177/cit177
ref84/cit84
ref1/cit1
ref123/cit123
ref196/cit196
ref7/cit7
ref45/cit45
ref52/cit52
ref184/cit184
ref114/cit114
ref186/cit186
ref116/cit116
ref110/cit110
ref182/cit182
ref2/cit2
ref112/cit112
ref77/cit77
ref71/cit71
ref188/cit188
ref20/cit20
ref118/cit118
ref89/cit89
ref19/cit19
ref96/cit96
ref107/cit107
ref191/cit191
ref109/cit109
ref13/cit13
ref193/cit193
ref105/cit105
ref38/cit38
ref90/cit90
ref195/cit195
ref64/cit64
ref6/cit6
ref18/cit18
ref136/cit136
ref65/cit65
ref171/cit171
ref97/cit97
ref101/cit101
ref76/cit76
ref32/cit32
ref39/cit39
ref168/cit168
ref132/cit132
ref91/cit91
ref12/cit12
ref179/cit179
ref121/cit121
ref175/cit175
ref33/cit33
ref129/cit129
ref44/cit44
ref70/cit70
ref125/cit125
ref9/cit9
ref152/cit152
ref154/cit154
ref27/cit27
ref151/cit151
ref159/cit159
ref92/cit92
ref157/cit157
ref31/cit31
ref88/cit88
ref160/cit160
ref143/cit143
ref53/cit53
ref149/cit149
ref162/cit162
ref46/cit46
ref49/cit49
ref75/cit75
ref24/cit24
ref141/cit141
ref50/cit50
ref138/cit138
ref100/cit100
ref25/cit25
ref173/cit173
ref103/cit103
ref72/cit72
ref51/cit51
ref135/cit135
ref68/cit68
ref94/cit94
ref130/cit130
ref146/cit146
ref26/cit26
ref73/cit73
ref69/cit69
ref165/cit165
ref95/cit95
ref108/cit108
ref192/cit192
ref4/cit4
ref30/cit30
ref47/cit47
ref127/cit127
References_xml – ident: ref82/cit82
  doi: 10.3892/or.2016.4811
– ident: ref21/cit21
  doi: 10.1093/hmg/ddt402
– ident: ref118/cit118
  doi: 10.1021/jm0506773
– ident: ref114/cit114
  doi: 10.1016/j.bmc.2018.02.042
– ident: ref94/cit94
  doi: 10.2174/1568026617666170707124126
– ident: ref136/cit136
  doi: 10.1080/13880209.2018.1563620
– ident: ref137/cit137
  doi: 10.1016/j.yjmcc.2018.10.007
– ident: ref93/cit93
  doi: 10.1016/j.ejmech.2014.03.018
– ident: ref180/cit180
  doi: 10.1021/acs.jmedchem.9b00946
– ident: ref20/cit20
  doi: 10.1038/417455a
– ident: ref172/cit172
  doi: 10.1021/acsmedchemlett.0c00395
– ident: ref173/cit173
  doi: 10.1016/j.ejmech.2019.112016
– ident: ref164/cit164
  doi: 10.1016/j.expneurol.2020.113281
– ident: ref86/cit86
  doi: 10.1016/j.bmcl.2010.12.079
– ident: ref57/cit57
  doi: 10.1158/2159-8290.CD-16-1020
– ident: ref12/cit12
  doi: 10.1074/jbc.R112.372300
– ident: ref26/cit26
  doi: 10.2217/epi.14.69
– ident: ref87/cit87
  doi: 10.1016/j.bmcl.2006.04.091
– ident: ref181/cit181
  doi: 10.1021/acs.jmedchem.8b00393
– ident: ref59/cit59
  doi: 10.3892/ijo.2018.4405
– ident: ref153/cit153
  doi: 10.3390/ijms20246213
– ident: ref99/cit99
  doi: 10.1016/j.ejmech.2018.03.006
– ident: ref167/cit167
  doi: 10.1016/j.bbamcr.2019.03.003
– ident: ref24/cit24
  doi: 10.1073/pnas.0803749105
– ident: ref39/cit39
  doi: 10.1038/nchembio.2134
– ident: ref53/cit53
  doi: 10.1182/blood-2011-10-387365
– ident: ref56/cit56
  doi: 10.1111/jnc.14849
– ident: ref186/cit186
  doi: 10.1038/nchembio.1223
– ident: ref126/cit126
  doi: 10.1016/j.brainresbull.2020.06.010
– ident: ref142/cit142
  doi: 10.1016/j.phrs.2019.104281
– ident: ref152/cit152
  doi: 10.1016/j.bmc.2018.10.022
– ident: ref106/cit106
  doi: 10.1016/j.ejmech.2018.09.024
– ident: ref30/cit30
  doi: 10.1021/acs.jmedchem.9b00924
– ident: ref113/cit113
  doi: 10.1016/j.bmc.2017.06.001
– ident: ref16/cit16
  doi: 10.1111/bjh.12384
– ident: ref191/cit191
  doi: 10.1021/acsmedchemlett.0c00046
– ident: ref179/cit179
  doi: 10.1002/cmdc.201500456
– ident: ref31/cit31
  doi: 10.2174/1568026619666181129141822
– ident: ref177/cit177
  doi: 10.1016/j.ejmech.2018.03.005
– ident: ref47/cit47
  doi: 10.1016/j.ccr.2007.08.001
– ident: ref61/cit61
  doi: 10.1016/j.gore.2019.07.010
– ident: ref64/cit64
  doi: 10.1016/j.ajpath.2017.12.016
– ident: ref36/cit36
  doi: 10.1021/acs.jmedchem.9b00946
– ident: ref6/cit6
  doi: 10.1038/nature07348
– ident: ref70/cit70
  doi: 10.1016/j.phrs.2020.105274
– ident: ref48/cit48
  doi: 10.1002/ejic.200400221
– ident: ref112/cit112
  doi: 10.1371/journal.pone.0205018
– ident: ref10/cit10
  doi: 10.1016/j.yjmcc.2019.04.003
– ident: ref13/cit13
  doi: 10.1002/med.20056
– ident: ref176/cit176
  doi: 10.1021/acs.jmedchem.5b01493
– ident: ref157/cit157
  doi: 10.1016/j.ejmech.2020.112998
– ident: ref45/cit45
  doi: 10.1016/j.ejmech.2020.112887
– ident: ref41/cit41
  doi: 10.1021/acs.biochem.9b00934
– ident: ref97/cit97
  doi: 10.1021/acs.jmedchem.9b00940
– ident: ref121/cit121
  doi: 10.1021/acs.jmedchem.0c00628
– ident: ref131/cit131
  doi: 10.1042/BSR20181916
– ident: ref40/cit40
  doi: 10.1038/nchembio.2140
– ident: ref49/cit49
  doi: 10.1021/jm990366q
– ident: ref139/cit139
  doi: 10.1007/s10753-018-0853-0
– ident: ref92/cit92
  doi: 10.1016/j.bmc.2019.06.036
– ident: ref25/cit25
  doi: 10.1155/2011/875824
– ident: ref69/cit69
  doi: 10.1016/j.biopha.2019.109357
– ident: ref165/cit165
  doi: 10.1021/acs.jmedchem.7b01404
– ident: ref105/cit105
  doi: 10.1016/j.bmcl.2018.06.037
– ident: ref158/cit158
  doi: 10.1002/cmdc.201500486
– ident: ref124/cit124
  doi: 10.1016/j.neuint.2016.08.004
– ident: ref133/cit133
  doi: 10.1021/acs.jmedchem.0c00567
– ident: ref104/cit104
  doi: 10.1021/acs.jmedchem.6b00157
– ident: ref196/cit196
  doi: 10.1007/s13238-018-0602-z
– ident: ref171/cit171
  doi: 10.1016/j.ejmech.2018.07.069
– ident: ref182/cit182
  doi: 10.1016/j.bmc.2019.115250
– ident: ref163/cit163
  doi: 10.1021/acschemneuro.8b00600
– ident: ref55/cit55
  doi: 10.1038/s41419-018-0788-2
– ident: ref84/cit84
  doi: 10.4149/gpb_2019058
– ident: ref19/cit19
  doi: 10.1074/jbc.M111.273730
– ident: ref89/cit89
  doi: 10.1002/mc.22852
– ident: ref101/cit101
  doi: 10.1038/sj.onc.1203925
– ident: ref183/cit183
  doi: 10.1021/acsmedchemlett.8b00487
– ident: ref193/cit193
  doi: 10.1158/1078-0432.CCR-14-2820
– ident: ref23/cit23
  doi: 10.1016/j.molcel.2005.04.021
– ident: ref100/cit100
  doi: 10.1016/j.ejmech.2020.112086
– ident: ref166/cit166
  doi: 10.1038/s41419-018-0688-5
– ident: ref8/cit8
  doi: 10.1007/s002800100300
– ident: ref154/cit154
  doi: 10.1021/acsmedchemlett.9b00084
– ident: ref11/cit11
  doi: 10.1021/acs.jmedchem.0c00830
– ident: ref170/cit170
  doi: 10.1021/acs.orglett.8b01118
– ident: ref17/cit17
  doi: 10.1016/j.ejmech.2016.05.047
– ident: ref141/cit141
  doi: 10.3390/antiox9070599
– ident: ref185/cit185
  doi: 10.1021/acsomega.0c00559
– ident: ref28/cit28
  doi: 10.1038/s41419-020-2586-x
– ident: ref81/cit81
  doi: 10.1080/07391102.2018.1557560
– ident: ref190/cit190
  doi: 10.1016/j.pharmthera.2017.02.027
– ident: ref148/cit148
  doi: 10.1016/j.ejmech.2018.04.046
– ident: ref174/cit174
  doi: 10.1080/13543776.2018.1526280
– ident: ref44/cit44
  doi: 10.1016/j.bmcl.2020.127023
– ident: ref127/cit127
  doi: 10.1073/pnas.1515882112
– ident: ref115/cit115
  doi: 10.1021/jm020449y
– ident: ref120/cit120
  doi: 10.1016/j.bmcl.2018.12.052
– ident: ref168/cit168
  doi: 10.1016/j.ejmech.2020.112193
– ident: ref175/cit175
  doi: 10.1002/cmdc.201700550
– ident: ref145/cit145
  doi: 10.3892/ijo.2019.4739
– ident: ref43/cit43
  doi: 10.1021/acs.jmedchem.9b01540
– ident: ref76/cit76
  doi: 10.1007/s10495-020-01607-3
– ident: ref116/cit116
  doi: 10.1021/acs.jmedchem.5b00099
– ident: ref110/cit110
  doi: 10.1146/annurev.biochem.70.1.369
– ident: ref146/cit146
  doi: 10.1021/acs.jmedchem.8b01936
– ident: ref192/cit192
  doi: 10.1016/j.ejmech.2020.112679
– ident: ref119/cit119
  doi: 10.1056/NEJMoa1513257
– ident: ref91/cit91
  doi: 10.1016/j.ejmech.2016.03.046
– ident: ref62/cit62
  doi: 10.3390/cancers11091327
– ident: ref90/cit90
  doi: 10.1016/j.leukres.2020.106398
– ident: ref187/cit187
  doi: 10.1080/13543776.2018.1508451
– ident: ref22/cit22
  doi: 10.1016/j.molcel.2007.05.033
– ident: ref68/cit68
  doi: 10.1016/j.biopha.2018.11.017
– ident: ref135/cit135
  doi: 10.1021/acsmedchemlett.9b00560
– ident: ref42/cit42
  doi: 10.1073/pnas.1718823114
– ident: ref109/cit109
  doi: 10.1016/j.bmcl.2012.10.007
– ident: ref123/cit123
  doi: 10.1073/pnas.1313893110
– ident: ref15/cit15
  doi: 10.1182/blood-2006-06-025999
– ident: ref50/cit50
  doi: 10.1016/j.bmc.2018.06.023
– ident: ref75/cit75
  doi: 10.1038/leu.2017.322
– ident: ref96/cit96
  doi: 10.1002/jcp.29776
– ident: ref169/cit169
  doi: 10.1021/acs.jmedchem.8b01090
– ident: ref83/cit83
  doi: 10.1016/j.taap.2019.03.017
– ident: ref60/cit60
  doi: 10.1158/1535-7163.MCT-17-0603
– ident: ref155/cit155
  doi: 10.1021/acschemneuro.9b00303
– ident: ref156/cit156
  doi: 10.1021/acs.jmedchem.0c00193
– ident: ref65/cit65
  doi: 10.3389/fphar.2019.00653
– ident: ref125/cit125
  doi: 10.3390/ijms21134589
– ident: ref188/cit188
  doi: 10.1038/nrd.2016.211
– ident: ref143/cit143
  doi: 10.3390/ijms18050954
– ident: ref1/cit1
  doi: 10.1038/nature05913
– ident: ref67/cit67
  doi: 10.1007/s13311-016-0501-z
– ident: ref51/cit51
  doi: 10.1073/pnas.0404603101
– ident: ref58/cit58
  doi: 10.1158/0008-5472.CAN-18-0161
– ident: ref162/cit162
  doi: 10.1039/C8OB00966J
– ident: ref52/cit52
  doi: 10.1038/43710
– ident: ref122/cit122
  doi: 10.1016/j.ejmech.2020.112868
– ident: ref128/cit128
  doi: 10.1021/jm301098e
– ident: ref184/cit184
  doi: 10.1021/acsmedchemlett.7b00012
– ident: ref2/cit2
  doi: 10.1038/450357a
– ident: ref108/cit108
  doi: 10.1182/blood-2009-04-214957
– ident: ref78/cit78
  doi: 10.18632/oncotarget.19019
– ident: ref138/cit138
  doi: 10.1042/CS20171417
– ident: ref178/cit178
  doi: 10.1016/j.bmc.2018.05.013
– ident: ref29/cit29
  doi: 10.1016/j.brainres.2020.146692
– ident: ref151/cit151
  doi: 10.2147/DDDT.S124977
– ident: ref189/cit189
  doi: 10.1016/j.semcancer.2020.02.006
– ident: ref80/cit80
  doi: 10.1080/07391102.2016.1231084
– ident: ref149/cit149
  doi: 10.1021/acs.jmedchem.8b01487
– ident: ref103/cit103
  doi: 10.2174/0929867325666180327093502
– ident: ref95/cit95
  doi: 10.1038/nrc1716
– ident: ref74/cit74
  doi: 10.1371/journal.pone.0173507
– ident: ref159/cit159
  doi: 10.1016/j.ejmech.2019.111950
– ident: ref9/cit9
  doi: 10.1016/j.it.2011.04.001
– ident: ref3/cit3
  doi: 10.1126/science.1172782
– ident: ref46/cit46
  doi: 10.1016/j.ejmech.2017.10.040
– ident: ref130/cit130
  doi: 10.1038/s41598-019-42237-3
– ident: ref35/cit35
  doi: 10.1016/j.molonc.2015.04.002
– ident: ref102/cit102
  doi: 10.1186/gb-2004-5-12-253
– ident: ref33/cit33
  doi: 10.1186/s13075-020-02258-0
– ident: ref32/cit32
  doi: 10.1080/13543776.2019.1708901
– ident: ref54/cit54
  doi: 10.18632/oncotarget.13738
– ident: ref107/cit107
  doi: 10.1021/jm200326p
– ident: ref27/cit27
  doi: 10.1186/s13045-018-0654-9
– ident: ref88/cit88
  doi: 10.1093/carcin/bgx121
– ident: ref98/cit98
  doi: 10.1016/j.ijbiomac.2020.06.115
– ident: ref79/cit79
  doi: 10.1021/jm8002894
– ident: ref14/cit14
  doi: 10.5582/irdr.2016.01024
– ident: ref72/cit72
  doi: 10.1186/s40425-019-0517-0
– ident: ref85/cit85
  doi: 10.1007/s11596-019-2024-4
– ident: ref4/cit4
  doi: 10.1016/j.cell.2007.02.005
– ident: ref161/cit161
  doi: 10.1016/j.bcp.2019.03.023
– ident: ref5/cit5
  doi: 10.1016/j.cell.2007.02.006
– ident: ref150/cit150
  doi: 10.1021/acs.jmedchem.9b01888
– ident: ref38/cit38
  doi: 10.1007/s13238-018-0602-z
– ident: ref132/cit132
  doi: 10.1021/acsmedchemlett.7b00223
– ident: ref71/cit71
  doi: 10.1038/s41375-020-0840-y
– ident: ref129/cit129
  doi: 10.3390/nano10010161
– ident: ref7/cit7
  doi: 10.1126/science.1179689
– ident: ref144/cit144
  doi: 10.1002/jcb.26841
– ident: ref160/cit160
  doi: 10.1021/acs.jmedchem.8b01590
– ident: ref194/cit194
  doi: 10.1016/S1470-2045(15)00584-7
– ident: ref134/cit134
  doi: 10.1021/ja102758v
– ident: ref37/cit37
  doi: 10.1016/j.bmcl.2018.05.057
– ident: ref111/cit111
  doi: 10.2174/092986712802884286
– ident: ref147/cit147
  doi: 10.1021/acs.jmedchem.7b01593
– ident: ref77/cit77
  doi: 10.1073/pnas.1608067113
– ident: ref73/cit73
  doi: 10.1038/s41388-020-1172-0
– ident: ref117/cit117
  doi: 10.1016/j.ejphar.2018.03.026
– ident: ref195/cit195
  doi: 10.3390/cancers12030756
– ident: ref18/cit18
  doi: 10.1073/pnas.96.9.4868
– ident: ref63/cit63
  doi: 10.1152/ajprenal.00186.2017
– ident: ref66/cit66
  doi: 10.1007/s11064-019-02882-6
– ident: ref140/cit140
  doi: 10.3389/fnagi.2020.00078
– ident: ref34/cit34
  doi: 10.1016/j.ejmech.2020.112831
SSID ssj0003123
Score 2.6097264
SecondaryResourceType review_article
Snippet Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1362
SubjectTerms Animals
Histone Deacetylase 6 - antagonists & inhibitors
Histone Deacetylase Inhibitors - chemistry
Histone Deacetylase Inhibitors - pharmacology
Histone Deacetylase Inhibitors - therapeutic use
Histone Deacetylases - chemistry
Humans
Models, Molecular
Structure-Activity Relationship
Title A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
URI http://dx.doi.org/10.1021/acs.jmedchem.0c01782
https://www.ncbi.nlm.nih.gov/pubmed/33523672
https://www.proquest.com/docview/2485513189
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS9xAFB7EPuhLba3WW8sRRCiYNZkkk4xvy-qigu3CKvgWzkwmuF6imPVh--t7ZpLsYkXUx4TMMNdzyfnOdxjbwTzVCaLwjE6VFyksPEVi0NN5nBihApO40glnv8XxRXR6GV_OHMX_I_g82Eddda4tWPHK3HV8bcvJk8j9xEWaWGer2xtOJW8Y8LBlB-ek19tUuVd6sQpJV88V0itWptM2_SX2p83ZqUEmN52nserovy8pHN85kS_sc2N4Qrc-KV_ZnCmX2UKvrfe2zHYHNYv1ZA_OZ0lZ1R7swmDGbz35xh67UEcU4L6AgcV3kbSEUQmOcqQ0cEhi1ownZJcbEHBSXo3UyBb1gRbmdwBDR1trKT9g-GAcLpDcAcAyhz5p2voHJRy2oJEVdtE_Ou8de03pBg-jIBp7oUkToxUZN1zEUcQ15tpXha8w0TzAlMwmiYo88zSOFTlNHH0ZFkIZpIec--Eqmy9pxGsMyB8is4gcgSiXkUSJKHOZKi1VLFQRy3X2i1Y2a65elbmoOg8y97JZ7qxZ7nUWtnud6YYD3ZbiuH2jlTdt9VBzgLzx_XZ7jDLaQxuBwdLcP1WZ448LSIzSqL_X52vao01-C0XCNz4wn022yC3GxhaoCbbYPO2d-UFG0lj9dDfjHzkdD6o
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9tAEB5FcIALUCgU6GMqVUhIONjr5_YWhUahPBQpAXGzdtdrkQIG4eQQfn1n13aiVkKIo1fe1XofM994Zr4B-CGyRMVCRI5WiXQCKXJHkhh0VBbGOpKejm3phIvLqH8V_L4Jb1oQNrkwNImSRiqtE3_BLuAdm7Y_JmbxVj-0XWWqypPkXSY8wozN1ekO5wLY95jfkIQzUu9Nxtwroxi9pMp_9dIrYNMqnd46XM-na2NN7trTiWyrl_-YHN_9PRuwVsNQ7FTn5gO0dLEJK92m-tsmHAwqTuvZEY4WKVrlER7gYMF2PduC5w5W_gV8zHFgor1IduK4QEtAUmg8IaGrJzNC6RojPC1ux3JsSvxgE_T3E4eWxNYQgODwSdsoQTIOUBQZ9kjvVr8r8aQJIfkIV71fo27fqQs5OCLwgonj6yTWShLUYVEYBEyJTLkyd6WIFfNEQiCKC0l2ehKGkkwoJlzu55HUgh4y5vrbsFTQjD8BknVEIInMgiDjARdcCJ7xRCouw0jmId-FQ1rZtL6IZWp97MxLbWO93Gm93LvgN1ueqpoR3RTmuH-jlzPv9VQxgrzx_vfmNKW0h8YfIwr9OC1TyybnkVClWe9Ux2w-okmF86OY7b3je77BSn90cZ6en16e7cMqM9E3pnSN9xmWaB_1F4JPE_nVXpa_x5AYCw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEA6ioL5439cIIgh2bdMzvi27Lt4srIL4UpI0xfWoi10f1l_vJG3XA0T0saEJ0xxzdCbfR8gOTyIZch5YSkbC8gRPLYFq0JKJH6pAOCo01AkXl8HxtXd64998ovpCIXIcKTdJfH2qe0laIgw4B7r9Xtct3qmnmi01szxq3zGdudNxV73RGSph16FuBRRO0cRXt-Z-GEXbJpl_tU0_OJzG8LSmye1QZFNv8lB77YuafPuG5vivb5ohU6U7CvVi_8ySEZXNkYlGxQI3R3bbBbb1YB-uPq5q5fuwC-0P1OvBPHmpQ5FngOcU2rrqC3UodDMwQCSZgiYqX9UfoLeuIICT7K4ruprqB6riv0PoGDBbDQQCnZ4y1YIYJADPEmih_S1-W0KzKiVZINeto6vGsVUSOljcc7y-5aooVFKgy0MD3_Oo5Im0RWoLHkrq8AidKcYFxuuR7wsMpSi3mZsGQnF8SKjtLpLRDCVeJoBREjpLGB54CfMYZ5yzhEVCMuEHIvXZCtnDmY3LA5nHJtdOndg0ltMdl9O9Qtxq2WNZIqNrgo7HX3pZw169Ahnkl_e3qx0V4xrqvAzP1PNrHhtUOQeVK0q9VGy14Yj6SpwbhHT1D9-zRcbbzVZ8fnJ5tkYmqS7C0Qw2zjoZxWVUG-hF9cWmOS_vt-Iajg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Review+of+Progress+in+Histone+Deacetylase+6+Inhibitors+Research%3A+Structural+Specificity+and+Functional+Diversity&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Zhang%2C+Xin-Hui&rft.au=Qin-Ma&rft.au=Wu%2C+Hui-Pan&rft.au=Khamis%2C+Mussa+Yussuf&rft.date=2021-02-11&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=64&rft.issue=3&rft.spage=1362&rft.epage=1391&rft_id=info:doi/10.1021%2Facs.jmedchem.0c01782&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_acs_jmedchem_0c01782
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon